AI Summary
✦ ClarthaVijaya Diagnostic Centre is an Indian diagnostic services provider serving patients through laboratory and imaging businesses. Laboratory services span pathology, microbiology, biochemistry, molecular diagnostics, and histopathology, while imaging includes CT, MRI, ultrasound, X-ray, and PET/CT. Health checkups and home sample collection broaden access and support volume growth. Revenue increased 19.5% year-on-year, with stable margins indicating growth has not yet required material profitability concessions. Profit grew 20.3%, modestly ahead of revenue, but ROE is unavailable for assessing capital efficiency. Debt/equity of 44.15 indicates extreme leverage, potentially magnifying reported shareholder returns and increasing balance-sheet sensitivity. At 83.3x earnings, the shares appear rich relative to a roughly 20% growth rate, implying investors already price sustained expansion. The valuation remains exposed to execution, competitive pricing, and the need to convert network growth into higher margins.
Price Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 10 analysts
Fundamentals
Fundamentals institutional score is 94 using growth durability 93.7.
Valuation
Valuation institutional score is 14 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 62 using mean target upside 1.3%; dispersion penalty 10.5; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 14 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 10 recent ticker-linked news items.
Signal Summary
Market intelligence remains Mixed. fundamentals provide support, while valuation and technical structure remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 49.3% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +2.39). Confidence: 75%.
Live forward EPS implies next-12-month EPS of ₹27.46. Applying the stock's normalized valuation corridor produces a fair range of ₹1,112.40 to ₹1,524.30, with base value near ₹1,439.73 (-1.7% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹27.46
Forward P/E
53.3x
Base Fair Value
₹1,439.73
Fair Range
₹1,112.40 - ₹1,524.30
Upside To Base
-1.7%
Estimate Source
Live forward EPS
Growth Estimate
+37.3%
5Y Average
39.85
Current
78.25
Overvalued
55.51
Undervalued
40.51
5Y Average
20.35
Current
39.97
Overvalued
27.25
Undervalued
12.45
5Y Average
8.96
Current
17.59
Overvalued
12.00
Undervalued
5.48
Peers & Comparison
Sector: Health Care · Theme: Hospitals & Diagnostic Centres
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
METROPOLIS HEALTHCARE LTD METROPOLISHospitals & Diagnostic Centres | +16.6% | 11.8% | 56.7x Undervalued | -32% vs avg | +6.6% |
FORTIS HEALTHCARE LTD FORTISHospitals & Diagnostic Centres | +17.5% | 11.0% | 65.0x Undervalued | -22% vs avg | -1.1% |
GLOBAL HEALTH LIMITED MEDANTAHospitals & Diagnostic Centres | +26.5% | 11.9% | 67.6x Undervalued | -18% vs avg | +6.3% |
NEPHROCARE HEALTH SERV L NEPHROPLUSHospitals & Diagnostic Centres | +22.2% | 8.1% | 83.9x Fair | +1% vs avg | +51.2% |
JUPITER LIFE LINE HOSP L JLHLHospitals & Diagnostic Centres | +18.2% | 12.0% | 53.5x Undervalued | -35% vs avg | +7.8% |
ASTER DM QUALITY CARE LTD ASTERDMHospitals & Diagnostic Centres | +21.6% | 6.5% | 134.4x Premium | +62% vs avg | +39.5% |
NARAYANA HRUDAYALAYA LTD. NHHospitals & Diagnostic Centres | +80.4% | 9.0% | 45.2x Undervalued | -45% vs avg | +1.0% |
KRISHNA INST OF MED SCI L KIMSHospitals & Diagnostic Centres | +35.3% | 4.8% | 157.0x Premium | +89% vs avg | +11.2% |
VIJAYA DIAGNOSTIC CEN LTD trades in line with peers (83.3x vs avg 82.9x), reflecting a fair valuation within the Hospitals & Diagnostic Centres cohort. Peers include METROPOLIS HEALTHCARE LTD, FORTIS HEALTHCARE LTD, GLOBAL HEALTH LIMITED — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹193 CrDec 2025Latest net profit
₹44 CrDec 2025Latest EPS
₹4.30Dec 2025Net margin
31.8%Dec 2025Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Dec 2025
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 118 | 119 | 136 | 129 | 141 | 142 | 170 | 156 | 160 | 177 | 189 | 193 |
| Expenses | 70.24 | 71.24 | 79.76 | 78.03 | 83.8 | 86.7 | 99.73 | 93.79 | 95.7 | 107 | 111 | 110 |
| Operating Profit | 36.77 | 35.05 | 42.71 | 36.69 | 42.34 | 40.53 | 55.35 | 45.61 | 47.04 | 51.73 | 59.11 | 61.43 |
| OPM % | 31.07% | 29.52% | 31.37% | 28.42% | 30.02% | 28.46% | 32.47% | 29.19% | 29.43% | 29.27% | 31.22% | 31.82% |
| Other Income | 4.53 | 5.86 | 6.92 | 5.25 | 3.41 | 3.83 | 4.6 | 4.99 | 5.68 | 7.23 | 5.15 | 5.55 |
| Interest | 5.76 | 5.87 | 5.84 | 6.05 | 5.95 | 6.05 | 6.07 | 6.26 | 6.58 | 6.91 | 7.21 | 7.95 |
| Depreciation | 11.32 | 12.44 | 13.66 | 14.4 | 14.91 | 15.19 | 15.4 | 16.86 | 17.11 | 18.36 | 19.4 | 21.25 |
| Profit before tax | 35.54 | 35.04 | 43.79 | 35.89 | 39.8 | 38.31 | 53.88 | 44.34 | 46.14 | 52.05 | 57.05 | 59.03 |
| Tax % | 24.25% | 25.8% | 24.98% | 23.93% | 23.34% | 24.67% | 26.22% | 24.38% | 25.99% | 25.55% | 25.15% | 25.11% |
| Net Profit | 26.92 | 26 | 32.85 | 27.3 | 30.51 | 28.86 | 39.75 | 33.53 | 34.15 | 38.75 | 42.7 | 44.21 |
| EPS in Rs | 2.64 | 2.55 | 3.21 | 2.47 | 2.98 | 2.82 | 3.87 | 3.26 | 3.23 | 3.76 | 4.15 | 4.30 |
All values in Rs. Crore unless otherwise stated. Source: CMIE Prowess, Quarterly Interim Standalone.